Literature DB >> 24074137

Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson's disease.

Eva Pirogovsky1, Mercedes Martinez-Hannon, Dawn M Schiehser, Stephanie L Lessig, David D Song, Irene Litvan, J Vincent Filoteo.   

Abstract

Few studies have examined instrumental activities of daily living (iADLs) in nondemented Parkinson's disease (PD), and the majority of these studies have used report-based measures, which can have limited validity. The present study had two main goals: (a) to examine the performance of nondemented PD patients on two performance-based measures of iADLs, which are considered more objective functional measures, and (b) to examine the cognitive, motor, and psychiatric correlates of iADL impairment in PD. Ninety-eight nondemented PD patients and 47 healthy older adults were administered performance-based measures that assess the ability to manage medications (Medication Management Ability Assessment) and finances (University of California, San Diego, UCSD, Performance-based Skills Assessment), the Mattis Dementia Rating Scale to assess global cognitive functioning, the Unified Parkinson's Disease Rating Scale Part III to assess motor symptom severity, and the Geriatric Depression Scale to assess depressive symptoms. Nondemented PD patients demonstrated significantly impaired scores relative to the healthy comparison group on the performance-based measure of financial management, but there were no significant group differences in medication management. Global cognitive functioning, motor severity, and depressive symptoms did not correlate with scores on either of the functional measures, except for a small correlation between depressive symptoms and financial management. The two performance-based measures of iADL functioning did not correlate with one another. These findings suggest that medication and financial management may not be predicted based on global cognitive functioning and that iADLs may not be represented by a single construct. Furthermore, these findings suggest the potential need for a multidimensional approach to assessing iADLs.

Entities:  

Mesh:

Year:  2013        PMID: 24074137     DOI: 10.1080/13803395.2013.838940

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  15 in total

1.  Everyday functioning in Parkinson's disease: Evidence from the Revised-Observed Tasks of Daily Living (OTDL-R).

Authors:  Francesca V Lopez; Beata Ferencz; Brittany Y Rohl; Erin Trifilio; Bonnie Scott; Michael S Okun; Michael Marsiske; Dawn Bowers
Journal:  Parkinsonism Relat Disord       Date:  2018-09-01       Impact factor: 4.891

Review 2.  Cognition in movement disorders: where can we hope to be in ten years?

Authors:  David Burn; Daniel Weintraub; Bernard Ravina; Irene Litvan
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

3.  Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.

Authors:  Laura Brennan; Andrew Siderowf; Jonathan D Rubright; Jacqueline Rick; Nabila Dahodwala; John E Duda; Howard Hurtig; Matthew Stern; Sharon X Xie; Lior Rennert; Jason Karlawish; Judy A Shea; John Q Trojanowski; Daniel Weintraub
Journal:  Mov Disord       Date:  2015-08-07       Impact factor: 10.338

4.  Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.

Authors:  Samantha K Holden; Luis D Medina; Brian Hoyt; Stefan H Sillau; Brian D Berman; Jennifer G Goldman; Daniel Weintraub; Benzi M Kluger
Journal:  Mov Disord       Date:  2018-10-10       Impact factor: 10.338

5.  Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.

Authors:  Benjamin L Deck; Sharon X Xie; Gyujae Choi; Jacqueline Rick; Andrew Siderowf; Samuel Rudovsky; Alice Chen-Plotkin; John E Duda; James F Morley; Nabila Dahodwala; John Q Trojanowski; Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2019-05-17

6.  REM Sleep Behavior Disorder in Parkinson's Disease: Change in Cognitive, Psychiatric, and Functional Outcomes from Baseline to 16-47-Month Follow-Up.

Authors:  Ryan Van Patten; Zanjbeel Mahmood; Delaney Pickell; Jacqueline E Maye; Scott Roesch; Elizabeth W Twamley; J Vincent Filoteo; Dawn M Schiehser
Journal:  Arch Clin Neuropsychol       Date:  2022-01-17       Impact factor: 3.448

7.  The Multiple Object Test as a performance-based tool to assess the decline of ADL function in Parkinson's disease.

Authors:  Aline Beyle; Hannah Glonnegger; Bernhard Cerff; Susanne Gräber; Daniela Berg; Inga Liepelt-Scarfone
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

8.  Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's Disease.

Authors:  Brenna Cholerton; Kathleen L Poston; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Krista Specketer; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  Mov Disord Clin Pract       Date:  2019-12-14

9.  Neural correlates of daily function: A pilot study of the white matter retrogenesis hypothesis and three separate performance-based functional assessments.

Authors:  Luis D Medina; Kate Heffernan; Samantha Holden; Abigail Simpson; Brianne M Bettcher
Journal:  Neuropsychology       Date:  2021-01       Impact factor: 3.295

Review 10.  Some Clinically Useful Information that Neuropsychology Provides Patients, Carepartners, Neurologists, and Neurosurgeons About Deep Brain Stimulation for Parkinson's Disease.

Authors:  Alexander I Tröster
Journal:  Arch Clin Neuropsychol       Date:  2017-11-01       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.